with less focus on the timeline of the instrument launch and more focus on “the technology, what we’re putting forward, and what we’re seeing.” “Our approach to efficiently sequencing ...

2025 notice from the China Ministry of Commerce ("MOFCOM") that Illumina is not permitted to export sequencing instruments into China. Illumina respects MOFCOM's decision and will continue to ...

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN stock.

"Our new fiscal 2025 guidance provides for limited further earnings contribution from China, and assumes a continuation of the macro trends we see today," said Ankur Dhingra, CFO of Illumina. "We will ...

With an installed base of over 25,000 sequencing instruments, including more than 21,600 active units as of mid-2024, Illumina has established a strong foothold in the market. The company’s ...

Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related ...

With an installed base of over 25,000 sequencing instruments, including more than 21,600 active units as of mid-2024, Illumina has established a strong foothold in the market. The company’s product ...

March 10 (Reuters) - Illumina (ILMN.O), opens new tab on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ...

Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego ...

Illumina (ILMN) responded to the March 4 notice from the China Ministry of Commerce that the company is not permitted to export sequencing ...

(RTTNews) - Illumina, Inc. (ILMN) responded on Monday to the notice from the China Ministry of Commerce stating that it is not permitted to export sequencing instruments into China. Illumina said ...